Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $172,560 - $263,082
1,438 Added 88.38%
3,065 $387,000
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $277,859 - $339,099
1,627 New
1,627 $299,000
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $170,948 - $222,682
1,235 Added 16.09%
8,909 $1.26 Million
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $1.18 Million - $1.52 Million
7,674 New
7,674 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $632,054 - $1.01 Million
3,940 New
3,940 $737,000
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $593,669 - $793,444
-4,220 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $1.03 Million - $1.65 Million
-6,389 Reduced 60.22%
4,220 $794,000
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $2.15 Million - $2.65 Million
8,699 Added 455.45%
10,609 $2.81 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $1.23 Million - $2.05 Million
-6,320 Reduced 76.79%
1,910 $552,000
Q2 2021

Aug 13, 2021

BUY
$165.87 - $220.95 $1.19 Million - $1.58 Million
7,165 Added 672.77%
8,230 $1.64 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $192,094 - $240,966
1,065 New
1,065 $207,000
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $506,701 - $654,604
-4,136 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $390,148 - $581,025
4,136 New
4,136 $511,000
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $1.18 Million - $1.49 Million
-16,002 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $1.23 Million - $1.53 Million
16,002 New
16,002 $1.23 Million
Q1 2019

May 13, 2019

SELL
$49.45 - $62.8 $1.39 Million - $1.77 Million
-28,153 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$48.26 - $68.88 $1.36 Million - $1.94 Million
28,153 New
28,153 $1.49 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.